Northern Trust’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.99M Sell
160,315
-75,218
-32% -$1.4M ﹤0.01% 2770
2025
Q1
$4.27M Sell
235,533
-9,990
-4% -$181K ﹤0.01% 2504
2024
Q4
$5.35M Buy
245,523
+42,923
+21% +$936K ﹤0.01% 2466
2024
Q3
$5.55M Buy
202,600
+147,911
+270% +$4.05M ﹤0.01% 2413
2024
Q2
$1.42M Buy
54,689
+36,198
+196% +$937K ﹤0.01% 3086
2024
Q1
$555K Buy
18,491
+3,190
+21% +$95.7K ﹤0.01% 3531
2023
Q4
$159K Buy
+15,301
New +$159K ﹤0.01% 3973
2023
Q3
Sell
-4,466
Closed -$54.2K 4487
2023
Q2
$54.2K Sell
4,466
-1,617
-27% -$19.6K ﹤0.01% 4206
2023
Q1
$77.4K Buy
6,083
+670
+12% +$8.52K ﹤0.01% 4146
2022
Q4
$34.2K Hold
5,413
﹤0.01% 4378
2022
Q3
$122K Buy
5,413
+27
+0.5% +$609 ﹤0.01% 4048
2022
Q2
$103K Sell
5,386
-12,992
-71% -$248K ﹤0.01% 4155
2022
Q1
$853K Sell
18,378
-952
-5% -$44.2K ﹤0.01% 3502
2021
Q4
$1.37M Buy
19,330
+430
+2% +$30.5K ﹤0.01% 3410
2021
Q3
$2.2M Sell
18,900
-1,020
-5% -$119K ﹤0.01% 3235
2021
Q2
$3.12M Buy
19,920
+3,859
+24% +$604K ﹤0.01% 3128
2021
Q1
$3.04M Sell
16,061
-2,293
-12% -$434K ﹤0.01% 3030
2020
Q4
$2.3M Sell
18,354
-16
-0.1% -$2.01K ﹤0.01% 3127
2020
Q3
$2M Buy
18,370
+2,005
+12% +$218K ﹤0.01% 3060
2020
Q2
$1.97M Buy
16,365
+2,091
+15% +$251K ﹤0.01% 3052
2020
Q1
$1.43M Sell
14,274
-139
-1% -$14K ﹤0.01% 3037
2019
Q4
$3.5M Sell
14,413
-262
-2% -$63.6K ﹤0.01% 2797
2019
Q3
$2.41M Buy
14,675
+3,250
+28% +$534K ﹤0.01% 3001
2019
Q2
$2.7M Buy
11,425
+1,663
+17% +$393K ﹤0.01% 2896
2019
Q1
$2.57M Buy
9,762
+5,611
+135% +$1.48M ﹤0.01% 2923
2018
Q4
$378K Buy
4,151
+743
+22% +$67.7K ﹤0.01% 3620
2018
Q3
$655K Buy
3,408
+2,579
+311% +$496K ﹤0.01% 3580
2018
Q2
$179K Buy
+829
New +$179K ﹤0.01% 3890